Vycor Medical (VYCO) Cash & Current Investments (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash & Current Investments came in at $173634.0 in Q1 2026, up 184.42% year-on-year from $61049.0 in Q1 2025, and up 99.62% on a QoQ basis from $86982.0 in Q4 2025.
Vycor Medical (VYCO) Cash & Current Investments (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Cash & Current Investments data on file, last reported at $173634.0 in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 184.42% year-over-year to $173634.0 in Q1 2026; TTM through Mar 2026 was $173634.0, a 184.42% increase from a year earlier, with the FY2025 full-year figure at $86982.0, down 17.67% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $173634.0, up from $86982.0 in the prior quarter.
- Over the last five years, Cash & Current Investments for VYCO reached as high as $173634.0 in Q1 2026 and fell as low as $32570.0 in Q3 2022.
- Historically, Cash & Current Investments has averaged $78433.8 across 5 years, with a median of $64230.0 in 2025.
- Across the five-year window, Cash & Current Investments slumped 59.87% in 2022 and jumped 184.42% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $37035.0 in 2022, then surged by 54.69% to $57291.0 in 2023, then surged by 84.41% to $105648.0 in 2024, then slipped by 17.67% to $86982.0 in 2025, then surged by 99.62% to $173634.0 in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $173634.0 in Q1 2026, $86982.0 in Q4 2025, and $64230.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 173,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,634.00 |
| Dec 31, 2025 | 86,982.00 |
| Sep 30, 2025 | 64,230.00 |
| Jun 30, 2025 | 99,700.00 |
| Mar 31, 2025 | 61,049.00 |
| Dec 31, 2024 | 105,648.00 |
| Sep 30, 2024 | 157,633.00 |
| Jun 30, 2024 | 119,296.00 |
| Mar 31, 2024 | 43,857.00 |
| Dec 31, 2023 | 57,291.00 |
| Sep 30, 2023 | 69,055.00 |
| Jun 30, 2023 | 53,404.00 |
| Mar 31, 2023 | 47,805.00 |
| Dec 31, 2022 | 37,035.00 |
| Sep 30, 2022 | 32,570.00 |
| Jun 30, 2022 | 43,619.00 |
| Mar 31, 2022 | 80,567.00 |
| Dec 31, 2021 | 90,941.00 |
| Sep 30, 2021 | 78,573.00 |
| Jun 30, 2021 | 108,687.00 |